by OncoAdmin | Dec 23, 2021 | Press Releases Eng
PRESS RELEASE Oncorena Secures Financing of the Company’s Continued Development of Orellanine, a Potential Breakthrough Therapy for Advanced Renal Cancer LUND, SWEDEN, December 23, 2021 – Oncorena, developing a potential breakthrough therapy for advanced renal...
by OncoAdmin | Mar 1, 2021 | Press Releases Eng
PRESS RELEASE Oncorena Receives Approval of First in Patient Trial with Orellanine as a Potential Breakthrough Therapy in Metastatic Renal Cancer Patients LUND, SWEDEN, March 1, 2021 – Oncorena, dedicated to developing a unique and potential breakthrough therapy...
by OncoAdmin | Jun 15, 2020 | Press Releases Eng
PRESS RELEASE Announcement Chief Business Officer (CBO) Pål Falck It is with great pleasure to welcome Pål Falck as a CBO for Oncorena, starting September 1, 2020. Pål brings a breadth of relevant experience and competence to strengthen our leadership in time for the...
by OncoAdmin | Nov 22, 2018 | Press Releases Eng
PRESS RELEASE Oncorena raises SEK 14.5 million to prepare for clinical study in advanced kidney cancer Oncorena Holding AB today announces that the company through a share issue has raised capital to build its organization and resources in preparation for clinical...
by OncoAdmin | Jun 26, 2018 | Press Releases Eng
PRESS RELEASE The Swedish oncology company Oncorena appoints new CEO Oncorena AB announces that a new full-time CEO has been appointed effective July 1.Lars Grundemar will lead the company in the intense development phase ahead. Oncorena develops a completely new and...
by OncoAdmin | Nov 10, 2016 | Press Releases Eng
PRESS RELEASE Oncorena strengthens its Board Oncorena Holding AB today announces that the company at an extra shareholder’s meeting decided to strengthen the board following the capitalization earlier this autumn. Björn Odlander is elected as new member of the board....
